Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katja Steiger

Showing results (131-140 of 370) with videos related to

Pageof 37
Sort By:
Cancer Research|May 4, 2021
TIMP1 Triggers Neutrophil Extracellular Trap Formation in Pancreatic CancerBenjamin Schoeps, Celina Eckfeld, Olga Prokopchuk, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 7, 2017
Somatostatin receptor expression related to TP53 and RB1 alterations in pancreatic and extrapancreatic neuroendocrine neoplasms with a Ki67-index above 20Björn Konukiewitz, Anna Melissa Schlitter, Moritz Jesinghaus, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|October 14, 2020
Expression of the EWSR1-FLI1 fusion oncogene in pancreas cells drives pancreatic atrophy and lipomatosisLisa Fahr, Yoshiaki Sunami, Nadja Maeritz, et al.
EJNMMI Research|April 27, 2020
Toxicity of a combined therapy using the mTOR-inhibitor everolimus and PRRT with [<sup>177</sup>Lu]Lu-DOTA-TATE in Lewis ratsJohannes Zellmer, Hsi-Yu Yen, Lena Kaiser, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 26, 2020
Preclinical investigation of neoatherosclerosis in magnesium-based bioresorbable scaffolds versus thick-strut drug-eluting stentsPhilipp Nicol, Anna Bulin, Maria Isabel Castellanos, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 27, 2018
Galectin-3 Targeting in Thyroid Orthotopic Tumors Opens New Ways to Characterize Thyroid CancerFrancesco De Rose, Miriam Braeuer, Sten Braesch-Andersen, et al.
Cancer Research|July 15, 2024
Metabolic Reprogramming Is an Initial Step in Pancreatic Carcinogenesis That Can Be Targeted to Inhibit Acinar-to-Ductal MetaplasiaThorsten Neuß, Min-Chun Chen, Nils Wirges, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 7, 2017
Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomasMoritz Jesinghaus, Björn Konukiewitz, Gisela Keller, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 26, 2018
Loss of TLR3 and its downstream signaling accelerates acinar cell damage in the acute phase of pancreatitisIvonne Regel, Susanne Raulefs, Simone Benitz, et al.
Cancers|July 8, 2020
Impact of Tumor Localization and Molecular Subtypes on the Prognostic and Predictive Significance of p53 Expression in Gastric CancerBianca Grosser, Meike Kohlruss, Julia Slotta-Huspenina, et al.
Pageof 37

Showing results (131-140 of 370) with videos related to

Sort By:
Pageof 37
Cancer Research|May 4, 2021
TIMP1 Triggers Neutrophil Extracellular Trap Formation in Pancreatic CancerBenjamin Schoeps, Celina Eckfeld, Olga Prokopchuk, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 7, 2017
Somatostatin receptor expression related to TP53 and RB1 alterations in pancreatic and extrapancreatic neuroendocrine neoplasms with a Ki67-index above 20Björn Konukiewitz, Anna Melissa Schlitter, Moritz Jesinghaus, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|October 14, 2020
Expression of the EWSR1-FLI1 fusion oncogene in pancreas cells drives pancreatic atrophy and lipomatosisLisa Fahr, Yoshiaki Sunami, Nadja Maeritz, et al.
EJNMMI Research|April 27, 2020
Toxicity of a combined therapy using the mTOR-inhibitor everolimus and PRRT with [<sup>177</sup>Lu]Lu-DOTA-TATE in Lewis ratsJohannes Zellmer, Hsi-Yu Yen, Lena Kaiser, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 26, 2020
Preclinical investigation of neoatherosclerosis in magnesium-based bioresorbable scaffolds versus thick-strut drug-eluting stentsPhilipp Nicol, Anna Bulin, Maria Isabel Castellanos, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 27, 2018
Galectin-3 Targeting in Thyroid Orthotopic Tumors Opens New Ways to Characterize Thyroid CancerFrancesco De Rose, Miriam Braeuer, Sten Braesch-Andersen, et al.
Cancer Research|July 15, 2024
Metabolic Reprogramming Is an Initial Step in Pancreatic Carcinogenesis That Can Be Targeted to Inhibit Acinar-to-Ductal MetaplasiaThorsten Neuß, Min-Chun Chen, Nils Wirges, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 7, 2017
Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomasMoritz Jesinghaus, Björn Konukiewitz, Gisela Keller, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 26, 2018
Loss of TLR3 and its downstream signaling accelerates acinar cell damage in the acute phase of pancreatitisIvonne Regel, Susanne Raulefs, Simone Benitz, et al.
Cancers|July 8, 2020
Impact of Tumor Localization and Molecular Subtypes on the Prognostic and Predictive Significance of p53 Expression in Gastric CancerBianca Grosser, Meike Kohlruss, Julia Slotta-Huspenina, et al.
Pageof 37